By characterization of downstream targets of VEGF-B that are important in regulating cell processes in the brain, especially dopaminergic neurons, it may be possible to develop more effective clinical interventions to promote neuronal protection in PD and other neurodegenerative diseases involving mitochondrial dysfunction. The gene discussed is VEGFB; the disease is neurodegenerative disease.